<?xml version="1.0" encoding="UTF-8"?><oembed><type>video</type><version>1.0</version><html>&lt;iframe src=&quot;https://www.loom.com/embed/689d89658b01431eb2a158494d8cc897&quot; frameborder=&quot;0&quot; width=&quot;3840&quot; height=&quot;2880&quot; webkitallowfullscreen mozallowfullscreen allowfullscreen&gt;&lt;/iframe&gt;</html><height>2880</height><width>3840</width><provider_name>Loom</provider_name><provider_url>https://www.loom.com</provider_url><thumbnail_height>2880</thumbnail_height><thumbnail_width>3840</thumbnail_width><thumbnail_url>https://cdn.loom.com/sessions/thumbnails/689d89658b01431eb2a158494d8cc897-307c4ec2179d598a.gif</thumbnail_url><duration>3900.5</duration><title>Time Is Tissue: Disrupting Biofilm to Prevent Amputation</title><description>This Loom explains how biofilms disrupt wound healing and increase the risk of limb loss and antimicrobial resistance. The speakers describe biofilms as communities embedded in extracellular polymeric substances, noting they can form in as little as five minutes, mature by 24 hours, and can be far more resistant than planktonic bacteria. Dr. Matthew Minty outlines a step down or step up approach, emphasizing early combination therapies and adjusting antiseptics as wounds improve, while noting that routine cultures may miss organisms in chronic wounds (an average of 11 distinct organisms reported by Mayo). Dr. Ragulski adds clinical context, including concerns about frequent or unnecessary antibiotic use, the need to treat the whole patient, and the importance of targeting and preventing biofilm recurrence through appropriate topical strategies. </description></oembed>